Drug intelligence / Profile preview

polymerized grass pollen allergenic extract

Development stage
Unknown
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Polymerized grass pollen allergenic extract is a subcutaneous allergen immunotherapy (SCIT) product developed by Inmunotek. The active ingredient consists of polymerized allergenic extracts derived from grass pollen species (primarily *Phleum pratense* and *Dactylis glomerata*), which are chemically modified (polymerized) using glutaraldehyde to reduce IgE-mediated allergenicity while retaining immunogenicity. This modification allows for a safer and more rapid up-dosing schedule. The drug is indicated for the treatment of grass pollen allergy, allergic rhinitis, allergic rhinoconjunctivitis, and allergic asthma in sensitized patients. It is marketed under brand names such as ALXOID and CLUSTOID.

Brand names
ALXOIDCLUSTOIDClustek
Other names
polymerized grass pollen extractpolymerized grass pollen allergoidglutaraldehyde-polymerized grass pollen extract
02

Targets

CLEC9A (C-type lectin domain family 9 member A)sIgE (Grass pollen-specific immunoglobulin E)Grass pollen peptide-reactive CD4+ T-cell receptor

Beyond the preview

Go deeper on polymerized grass pollen allergenic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polymerized grass pollen allergenic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call